Market Newsdesk

ROLLING MEADOWS, Ill., April 1, 2021 /PRNewswire/ — Arthur J. Gallagher & Co. today announced that its risk management services subsidiary, Gallagher Bassett Services, Inc. (GB), has acquired Pleasantville, NY-based Terrier Claims Services, Inc. (TCS) and its affiliate, MT Investigations, LLC. Terms of the transaction were not disclosed.

Founded in 1996, TCS is a full-service claims investigation firm dedicated exclusively to insurance defense, third-party administrators, defense attorneys and government agencies. The team conducts extensive field investigations, trial preparation and property adjusting services in New York, New Jersey, Pennsylvania and Connecticut, in addition to nationwide desktop investigations. Daniel Sullivan, Edward Sullivan, David Perini and their associates will remain in their current locations in Pleasantville, Albany and Mineola, NY; Wall, NJ; and Philadelphia, under the direction of Jim Bond, Executive VP – Gallagher Bassett Technical Services, as an integral part of GB’s Construction Practice.

“TCS will expand and enhance GB’s field investigative and property adjusting capabilities, particularly with complex construction claims. Through their embedded claims team model, clients can immediately investigate and mitigate both the frequency and cost of claims,” said J. Patrick Gallagher, Jr., Chairman, President and CEO. “We are excited to welcome Dan, Edward, David and their team to our growing, global company.”

Arthur J. Gallagher & Co. (NYSE:AJG), a global insurance brokerage, risk management and consulting services firm, is headquartered in Rolling Meadows, Illinois. The company has operations in 49 countries and offers client service capabilities in more than 150 countries around the world through a network of correspondent brokers and consultants.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/arthur-j-gallagher–co-acquires-terrier-claims-services-inc-and-mt-investigations-llc-301260590.html

SOURCE Arthur J. Gallagher & Co.

TORONTO, April 1, 2021 /PRNewswire/ – NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave”) (CSE: SPOR) (FWB: 0XM2) (OTCPK: TRMNF) an investment issuer that provides capital and support services, today announced its plans to expand Way of Will’s brand presence on the e-commerce giant, Amazon.

Way of Will, a health and wellness brand offering a large assortment of natural skin care and body care, is in preparation of listing to widen our selection on the Amazon US and Canada platform at the beginning of May this year. This preparation incudes:

• Creative assets for listings
• Data analytics including search demands
• Competitive analysis
• Keywords and product optimization
• Inventory fulfillments to FBA

Once the majority of the brand’s collection are added to the e-commerce platform, the company is expected to see a growth of 20% in revenue. The goal of increasing the selection of products on Amazon is to optimize sales and fortify the company’s growth strategy.

Products that are currently available on Amazon include Way of Will’s popular massage oil, deodorants, face mask sprays, nail serum, and their Athletic Collection skin-care products. New products that customers can expect to find on Amazon starting in May will include bestsellers such as hand washes, hand & body lotions, hydrating face spray, and face oil serums. Amazon US customers will also be able to purchase mushroom capsules and mushroom powder, which are a part of Way of Will’s new collection of Functional Mushroom products.

The health and wellness brand is widely loved for offering products that are cruelty-free, incorporating all-natural ingredients that are genuinely good for the skin, and eliminating harsh ingredients from their formulations found in conventional skin-care products. In the past year, the company has also made a commitment to move toward more eco-friendly packaging for a more environmentally responsible approach to their business.

“We’re thrilled to be adding almost our entire assortment of products to both Amazon US and Amazon Canada,” commented Willie Tsang, founder and CEO of Way of Will. “The existing products that we’ve had on Amazon for the past years have been well-received, so we’re confident that the new products will be a welcoming addition to our selection. Our goal is to maximize sales by diversifying our sales channels and gain more exposure on different platforms, so we can have a greater reach and prevent dependency on any one channel.”

ABOUT NEW WAVE HOLDINGS CORP.

New Wave Holdings Corp. (CSE: SPOR, FWB: 0XM2, OTCPK: TRMNF) is an investment issuer focused on the burgeoning nutraceutical and psychedelic sector and support for adaptive and progressive health and wellness products and therapies. New Wave subsidiaries contain various health and beauty products within its portfolio of non-psychoactive plants and fungi as it continues to expand its product distribution through vertical integration to provide end to end solutions while capturing a high margin business model.

Investors interested in connecting with New Wave Holdings can learn more about the company and contact the team at http://newwavecorp.com.

Information relating to WAY OF WILL INC., contained in this news release was provided by WAY OF WILL INC. and/or its agent and has not been independently verified by the Company. The Company does not take responsibility for the accuracy of such information.

The CSE has not in any way passed on the merits of the Acquisition, and neither has approved nor disapproved the contents of this press release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. 

FORWARD-LOOKING INFORMATION DISCLAIMER

Certain statements contained in this news release may constitute forward–looking information, including but not limited to, applicable regulatory approval in connection with the Acquisition, the closing of the Acquisition, expansion of operations, size and quality of future tournaments and projections regarding attendance at future events. Forward–looking information is often, but not always, identified by the use of words such as “anticipate”, “plan”, “estimate”, “expect”, “may”, “will”, “intend”, “should”, and similar expressions. Forward–looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward–looking information. The Company’s actual results could differ materially from those anticipated in this forward–looking information as a result of competitive factors and competition for investment opportunities, challenges relating to operations in international markets, transaction execution risk, changes to the Company’s strategic growth plans, and other factors, many of which are beyond the control of the Company. The Company believes that the expectations reflected in the forward–looking information are reasonable based on current expectations and potential investment pipeline, but no assurance can be given that these expectations will prove to be correct and such forward–looking information should not be unduly relied upon. Any forward–looking information contained in this news release represents the Company’s expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward–looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.

View original content to download multimedia:http://www.prnewswire.com/news-releases/new-wave-subsidiary-way-of-will-inc-announces-plans-to-expand-brand-presence-on-amazon-us-and-canada-301260691.html

SOURCE New Wave Holdings Corp.

OVERLAND PARK, Kan., April 1, 2021 /PRNewswire/ — QTS Realty Trust, Inc. (NYSE: QTS) today announced that the Company will issue its financial results for the quarter ended March 31, 2021 after market close on Tuesday, April 27, 2021. The Company will conduct a conference call and webcast on Wednesday, April 28, 2021 at 7:30 a.m. Central Time / 8:30 a.m. Eastern Time. The dial-in number for the conference call is (877) 883-0383 (U.S.) or (412) 902-6506 (International). The participant entry number is 2174042# and callers are asked to dial in ten minutes prior to start time. A link to the live broadcast and the replay will be available on the Company’s website (www.qtsdatacenters.com) under the Investors tab.

About QTS
QTS Realty Trust, Inc. (NYSE: QTS) is a leading provider of data center solutions across a diverse footprint spanning more than 7 million square feet of owned mega scale data center space throughout North America and Europe. Through its software-defined data center platform, QTS is able to deliver secure, compliant infrastructure solutions, robust connectivity and premium customer service to leading hyperscale technology companies, enterprises, and government entities. Visit QTS at www.qtsdatacenters.com, call toll-free 877.QTS.DATA or follow on Twitter @DataCenters_QTS.

Investor Relations Contact:

Stephen Douglas – EVP Finance
[email protected]

Media Contact:

Carter B. Cromley

(703) 861-8245
[email protected]

View original content:http://www.prnewswire.com/news-releases/qts-realty-trust-inc-schedules-first-quarter-2021-earnings-release-and-conference-call-301260647.html

SOURCE QTS Realty Trust, Inc.

NETANYA, Israel, April 1, 2021 /PRNewswire/ — Orbit Communications Systems Ltd. (TASE: ORBI), a leading global provider of maritime and airborne satcom terminals, tracking ground station solutions, and mission-critical airborne audio management systems announced today that it has received an order from a new customer, a leading European integrator, for OceanTRx4 Mil satellite communications systems for new naval military platforms for a total of approximately $3.1 million. Delivery of the systems, which will provide the fleet with continuous satellite broadband connectivity, is expected to begin during 2022.

“We are proud of the choice of this leading European defense integrator to acquire one of Orbit’s leading systems,” said Daniel Eshchar, CEO of Orbit. “The OceanTRx4 Mil platform is one of the most advanced naval satellite communication solutions in the world. The platform supports both military and civilian bands allowing our customers to use dual frequency bands on a single military system. This order strengthens Orbit’s technological leadership in maritime satellite communications systems in general and advanced navies in particular.”

About Orbit’s OceanTRx 4 Mil System

OceanTRx 4 Mil is a Maritime Satcom Terminal, based on the OceanTRx4 platform but with advanced military features. A patented satellite communication system designed for maritime platforms and supports a variety of configurations of 1.15-meter diameter antenna systems, operating at Ku, X and Ka frequencies including simultaneous operation of a variety frequencies for global operation. The OceanTRx 4 Mil system is designed for quick and convenient installation, maintenance and upgrade, combining RF performance and exceptional system availability for security customers

About ORBIT:

Orbit Communication Systems Ltd. (TASE: ORBI), a leading global provider of airborne communications and satellite-tracking maritime and ground-station solutions, is helping to expand and redefine how we connect. You’ll find Orbit systems on airliners and jet fighters, cruise ships and navy vessels, ground stations and offshore platforms. We deliver innovative, cost-effective and highly reliable solutions to commercial operators, major air forces and navies, space agencies and emerging New Space companies.

For more information, please visit http://orbit-cs.com/

Media Contacts:
For Orbit:
Marketing Communications
[email protected]

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/orbit-communications-reports-receiving-an-order-from-a-leading-european-integrator-for-innovative-military-maritime-satellite-communication-systems-for-a-total-of-approximately-3-1-million-301260645.html

SOURCE Orbit Communication Systems Ltd

HERSHEY, Pa., April 1, 2021 /PRNewswire/ — The Hershey Company (NYSE:HSY) announced today that it will release its first-quarter sales and earnings results at 7:00 a.m. on Thursday, April 29, 2021, and hold a conference call with analysts at 8:30 a.m. ET on that date. The company will webcast live its first-quarter conference call via the Hershey corporate website.  Please click here and navigate to “CALENDAR OF EVENTS” for webcast details.

If you are unable to click on the link above, please copy and paste the URL below into a web browser https://www.thehersheycompany.com/content/corporate_SSF/en_us/investors/events-reports-releases/calendar-of-events.html

 

 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/hershey-to-webcast-first-quarter-conference-call-301260687.html

SOURCE The Hershey Company

FREMONT, Calif., April 1, 2021 /PRNewswire/ — Enovix Corporation, the leader in the design and manufacture of next generation 3D Silicon™ Lithium-ion batteries, today announced the appointment of Steffen Pietzke as Chief Financial Officer, effective immediately. In his role, Pietzke will lead the finance organization as Enovix prepares to become a publicly listed company. The company’s merger with Rodgers Silicon Valley Acquisition Corp (Nasdaq: RSVA, RSVAU, RSVAW), which was announced in February 2021, is expected to close in the second quarter of 2021. Additionally, Pietzke will build out and oversee financial operations and planning to support the company’s battery production and growth plans.

“Steffen has decades of knowledge and experience guiding companies through major financial events — his experience is exactly what Enovix needs as we transition from a privately-held to a publicly-traded company,” said Harrold Rust, Enovix CEO and co-founder. “His expertise and leadership will be an incredibly valuable asset to our leadership team.”

Pietzke brings more than 20 years of experience guiding public and private technology, life science and transportation companies across the U.S., Europe and Asia. Prior to Enovix, Pietzke was Vice President, Finance and Chief Accounting Officer at ALX Oncology Holdings Inc., where he managed all facets of corporate accounting and finance. Prior to ALX Oncology, Pietzke was Senior Vice President, Finance and Chief Accounting Officer at Tricida, Inc. Among his accomplishments, Pietzke has successfully managed finance organizations during two initial public offerings — ALX Oncology’s $186 million IPO in 2020 and Tricida’s $256 million IPO in 2018. He spent the first fifteen years of his career at Ernst & Young LLP and PricewaterhouseCoopers.

“The Enovix vision to support the advancement of mobile devices and electric vehicles through its next-generation batteries is what drew me to the company. Many startups have tried to develop breakthrough batteries, but few have made it as far as Enovix, which is poised to ramp commercial production at scale,” said Pietzke. “I’m excited to join Enovix and lead the finance organization at such a pivotal moment for the company. My expertise in establishing public company infrastructure will support Enovix’s long term growth as a commercial organization.”

About Enovix

Enovix is the leader in advanced silicon-anode lithium-ion battery development and production. The company’s proprietary 3D cell architecture increases energy density and maintains high cycle life. Enovix is building an advanced silicon-anode lithium-ion battery production facility in the U.S. for volume production. The company’s initial goal is to provide designers of category-leading mobile devices with a high-energy battery so they can create more innovative and effective portable products. Enovix is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable widespread utilization of renewable energy. For more information, go to www.enovix.com.

About Rodgers Silicon Valley Acquisition Corp.

Rodgers Silicon Valley Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. RSVAC’s mission is to provide fundamental public technology investors with early access to an excellent Silicon Valley technology company with a focus on green energy, electrification, storage, Smart Industry (IoT), Artificial Intelligence and the new automated-manufacturing wave. For more information, go to www.rodgerscap.com.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the federal securities laws, including with respect to the completion of its initial production facility, qualification and commercialization of its advanced silicon-anode lithium-ion battery. These forward-looking statements generally are identified by the words “intend,” “future,” “may,” “will,” “would,” “will be,” “expect,” “project,” “believe,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. All statements, other than statements of present or historical fact included in this press release, regarding the timeline for completion of the pending merger with Rogers Silicon Valley Acquisition Corp, or the Company’s initial manufacturing facility, qualification and commercial delivery of its advanced silicon-anode lithium-ion battery are forward-looking statements. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release.

There may be additional risks that the Company presently knows, or that the Company currently believes are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. The Company anticipates that subsequent events and developments will cause the Company’s assessments to change. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements as predictions of future events, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by applicable law. The Company gives no assurance that it will achieve its expectations.

View original content to download multimedia:http://www.prnewswire.com/news-releases/enovix-announces-new-chief-financial-officer-301260698.html

SOURCE Enovix

PHOENIX, April 1, 2021 /PRNewswire/ — Pipistrel has selected Honeywell’s (NYSE: HON) next-generation Attitude Heading Reference System and Air Data Module for its Nuuva V300 cargo unmanned aerial vehicle (UAV). The technologies provide critical navigation and motion-sensing data and will work in tandem with Honeywell’s Compact Fly-By-Wire system onboard the aircraft.

If the fly-by-wire system operates as the “brain” of an aircraft’s flight controls, the Attitude Heading Reference System (AH-2000) and Air Data Module (ADM) act as the “heart,” supplying critical motion data to all avionics systems and many mechanical systems. Both the AH-2000 and ADM are key enablers for safe and efficient vehicle operations with potential to serve several flight applications, including urban air mobility vehicles, commercial aircraft, business jets and helicopters. 

“Nuuva V300’s groundbreaking operational concept requires highly accurate, dependable and robust navigation sensors, and the AH-2000 and ADM are key enablers of this functionality,” said Tine Tomažič, chief technology officer, Pipistrel. “This technology allows us to deliver simple and intuitive mouse-click control to fly the vehicle, eliminating the need for operators to be trained with traditional piloting skills, which helps ensure rapid scale-up of operations for our customers.”

Pipistrel’s Nuuva V300 is a long-range, large-capacity, autonomous UAV. It will take off and land vertically with battery power, meaning it does not require a runway, and has significantly lower operating costs than helicopters. It can carry loads up to 460 kilograms (around 1,000 pounds) for more than 300 kilometers (about 186 miles), making it an ideal solution for deliveries to areas traditionally accessible only by helicopter.

“Unmanned aircraft, especially those delivering packages, must be equipped with high-performing inertial systems to ensure fly-by-wire systems are provided the best possible information on location, speed and position,” said Matt Picchetti, vice president and general manager, Navigation & Sensors, Honeywell Aerospace. “Vehicles like Nuuva V300 will change the way logistics companies fulfill package deliveries, and we’re proud to add our growing list of onboard technologies to enhance safety and make flying easier.”

The AH-2000 uses Honeywell’s next-generation, industry-leading, Micro-Electro-Mechanical Systems (MEMS)-based inertial sensors to deliver aircraft attitude and velocity information. It delivers safety-critical attitude and velocity data to drive the fly-by-wire flight control system and provides navigation data to the fly-by-wire guidance system. This data provides the high level of safety normally seen on commercial aircraft but in a more compact size. This data is necessary for fly-by-wire control, navigation and cockpit displays.

Honeywell’s ADM utilizes the industry’s most stable pressure-sensing technology to provide safety-critical avionics with measurements for accurate altitude and airspeed.

Honeywell is a major player in the emerging UAM segment, offering a full line of avionics, flight control, navigation, radar, communications, actuation, cooling, motors and turbo-electric propulsion systems — all tailored for piloted vertical take-off and landing, urban air mobility and unmanned cargo vehicles. Honeywell also offers aerospace integration and certification expertise for enabling the commercialization of these vehicles.

For more information on Honeywell’s advanced solutions, visit the UAS/UAM page on the Honeywell Aerospace website.

About Honeywell

Honeywell Aerospace products and services are found on virtually every commercial, defense and space aircraft. The Aerospace business unit builds aircraft engines, cockpit and cabin electronics, wireless connectivity systems, mechanical components and more. Its hardware and software solutions create more fuel-efficient aircraft, more direct and on-time flights and safer skies and airports. For more information, visit www.honeywell.com or follow us at @Honeywell_Aero. 

Honeywell (www.honeywell.com) is a Fortune 100 technology company that delivers industry-specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable. For more news and information on Honeywell, please visit www.honeywell.com/newsroom.

About Pipistrel

Pipistrel is a world-leading small aircraft designer and manufacturer, specialized in energy-efficient and affordable high-performance aircraft. With more than 30 years of experience, Pipistrel has produced more than 2200 aircraft to-date, gaining significant international reputation by delivering unique, innovative products to passionate customers on all continents. First-to-fly an electric two-seater in 2007 and the winner of the NASA Green Flight Challenge in 2011 with the World’s first electric four-seat aeroplane, Pipistrel has designed nine different experimental and serially produced electric aircraft, including the first type certified electric aeroplane, the Velis Electro. It has also developed propulsion systems, including batteries, power controllers and electric motors, for small and general aviation class of aircraft for NASA and Siemens, among others. With involvement in standardisation committees, i.e. ASTM F44.40, F39.05, SAE AE7-D, Pipistrel is helping to enable the future market of hybrid-electric aviation.

Pipistrel Vertical Solutions, the company’s R&D division, holds an EASA Design Organisation Approval and has the capability of bringing a new aircraft design concept from a basic idea into a certified design, ready for production. The division is also developing an electric eVTOL air taxi, as well as a hydrogen fuel-cell powered 19-seat miniliner/microfeeder, aimed at revolutionising the intra-European transport market.

Contacts:

Media
Amanda Jensen                                                                       
(602) 245-9033                                      
[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/honeywell-to-provide-critical-navigation-and-sensor-technology-for-pipistrels-unmanned-cargo-aircraft-301260540.html

SOURCE Honeywell

NEW YORK, April 1, 2021 /PRNewswire/ — Synaptogenix, Inc. (OTC: SNPX), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced an update on its ongoing National Institute of Health (“NIH”) sponsored Phase 2b clinical trial of Bryostatin-1 in patients suffering from moderately severe Alzheimer’s disease (“AD”).

To date, the Company has dosed 43 of its target 100 patients. Seventeen sites are currently live. The monitoring of the balance between the placebo group and the drug group has been completed on a blinded basis by an independent review and there have been no imbalances or safety issues referable to Bryostatin-1 reported thus far.

“By including two 11-week cycles of Bryostatin-1 dosing, in the absence of Namenda, we hope to confirm and extend the significant improvement of 4.8 Severe Impairment points (SIB) over baseline already observed with each single 11-week cycle in two prior pilot Phase 2 clinical trials for advanced AD patients,” stated Dr. Daniel Alkon, President and Chief Scientific Officer. 

Alan Tuchman M.D., Chief Executive Officer, commented, “Despite concerns that Covid-19 might interfere with our trial progress, we are on schedule and enrolling well. By having adequate safeguards against baseline imbalance and a more conventional six-month duration trial, we expect to avoid any issues with placebo effects. We look forward to sharing further updates on this trial when available.”

About Synaptogenix, Inc.

Synaptogenix is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases. Synaptogenix has conducted clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer’s disease. Preclinical studies have also demonstrated Bryostatin’s regenerative mechanisms of action for the rare disease, Fragile X syndrome, and for other neurodegenerative disorders such as multiple sclerosis, stroke, and traumatic brain injury. The U.S. Food and Drug Administration has granted Orphan Drug Designation to Synaptogenix for Bryostatin-1 as a treatment for Fragile X syndrome. Bryostatin-1 has already undergone testing in more than 1,500 people in cancer studies, thus creating a large safety data base that will further inform clinical trial designs.

Additional information about Synaptogenix, Inc. may be found on its website: www.synaptogen.com. 

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. These forward-looking statements include statements regarding the Phase 2 clinical trial of Bryostatin-1 and further studies, and continued development of use of Bryostatin-1 for AD and other cognitive diseases. Such forward-looking statements are subject to risks and uncertainties and other influences, many of which the Company has no control over. There can be no assurance that the clinical program for Bryostatin-1 will be successful in demonstrating safety and/or efficacy, that we will not encounter problems or delays in clinical development, or that Bryostatin-1 will ever receive regulatory approval or be successfully commercialized. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Additional factors that may influence or cause actual results to differ materially from expected or desired results may include, without limitation, the Company’s inability to obtain adequate financing, the significant length of time associated with drug development and related insufficient cash flows and resulting illiquidity, the Company’s patent portfolio, the Company’s inability to expand its business, significant government regulation of pharmaceuticals and the healthcare industry, lack of product diversification, availability of the Company’s raw materials, existing or increased competition, stock volatility and illiquidity, and the Company’s failure to implement its business plans or strategies. These and other factors are identified and described in more detail in the Company’s filings with the Securities and Exchange Commission. The Company does not undertake to update these forward-looking statements.

Contact information:

Investors and Media

Investor Relations
Brett Maas
Hayden IR
[email protected]
(646)536-7331

Robert Weinstein

Chief Financial Officer
Synaptogenix, Inc.
[email protected]

View original content:http://www.prnewswire.com/news-releases/synaptogenix-announces-phase-2b-bryostatin-1-clinical-trial-update-301260630.html

SOURCE Synaptogenix, Inc.

INDIANAPOLIS and BOSTON, April 1, 2021 /PRNewswire/ — Corteva Agriscience LLC (NYSE: CTVA), a leading pure-play agriculture company, and Ginkgo Bioworks, Inc. (“Ginkgo”) the organism company, announced today that they have entered into a multi-year agreement to apply the power of synthetic biology to design innovative crop protection technologies. This collaboration combines Corteva’s deep knowledge of natural product discovery and agricultural expertise with Ginkgo’s extensive cell engineering platform and DNA codebase to explore the next generation of naturally-inspired sustainable solutions. Ultimately, this collaboration aims to provide farmers with new solutions to combat invasive pests and evolving resistance challenges.

The Food and Agricultural Organization of the United Nations (FAO) estimates that 20 to 40% of global crop production is lost to pests annually. Consequently, plant diseases and invasive insects/weeds cost the global economy billions of dollars. Novel natural products and their inspired analogs have tremendous potential to provide sustainable options for farmers to protect crop yield. By working with Ginkgo, Corteva will accelerate the discovery and optimization of complex natural products through synthetic biology.

“Sustainable food and agriculture systems are critical to the growing population,” said Sam Eathington, Senior Vice President and Chief Technology Officer, Corteva Agriscience. “As leaders in natural product development, we are committed to solving the challenges facing farmers sustainably through innovation. We are excited to collaborate with Ginkgo Bioworks to discover, optimize and scale groundbreaking, naturally-inspired crop protection solutions.”

Companies across numerous industries use Ginkgo’s cell programming platform to find better, more sustainable ways to create products, including food ingredients, fragrances, cosmetics, medicines, and more. By enabling the design of organisms that can produce valuable biological products, Ginkgo helps accelerate the development of innovative, bio-based solutions to the world’s most pressing environmental challenges.

“At Ginkgo, we fundamentally believe that biology is the best technology on the planet because it can move more rapidly and efficiently than traditional approaches with less impact on the environment,” said Jason Kelly, Chief Executive Officer of Ginkgo Bioworks, Inc. “Food loss is a significant issue impacting so many communities around the world, and we’re excited to see what Ginkgo and Corteva can accomplish together to advance novel, environmentally sustainable, biological solutions to protect crops around the world.”

About Ginkgo Bioworks, Inc.
Headquartered in Boston, Ginkgo uses the most advanced technology on the planet—biology—to grow better products. The company’s cell programming platform is enabling the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Ginkgo is also actively supporting a number of COVID-19 response efforts, including community testing, epidemiological tracing, vaccine development and therapeutics discovery. For more information, visit www.ginkgobioworks.com.

About Corteva Agriscience
Corteva Agriscience is a publicly traded, global pure-play agriculture company that provides farmers around the world with the most complete portfolio in the industry – including a balanced and diverse mix of seed, crop protection and digital solutions focused on maximizing productivity to enhance yield and profitability. With some of the most recognized brands in agriculture and an industry-leading product and technology pipeline well positioned to drive growth, the company is committed to working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. Corteva Agriscience became an independent public company on June 1, 2019 and was previously the Agriculture Division of DowDuPont. More information can be found at www.corteva.com.

Media Contacts:


[email protected]



[email protected]
 

View original content:http://www.prnewswire.com/news-releases/corteva-agriscience-collaborates-with-ginkgo-bioworks-to-bolster-crop-protection-301260562.html

SOURCE Ginkgo Bioworks

With a Strong Cash Position, No Debit, Growing Mesh Connector™ Sales, Venzee is Well-Positioned to Deliver on 2021 Objectives

CHICAGO, April 1, 2021 /PRNewswire/ – Venzee Technologies Inc. (TSX-V: VENZ) (“Venzee” or the “Company“) a smart tech platform that automates the distribution of consumer-facing product information to retailers, is pleased to announce the Company has received over $1.6M from the exercise of warrants in Q1 2021.

According to Venzee Technologies COO, Peter Montross, “In addition to the $2.1M in financing closed last December, this additional $1.6M puts Venzee in a very strong cash position to deliver on its 2021 objectives. We continue to meet our internal sales projections while growing our sales pipeline at an accelerated pace.”

Mr. Montross continued, “As we continue to win business from Fortune 100 companies, our brand is becoming more widely recognized and respected in the digital supply chain, leading to further sales opportunities and growth. We believe 2021 is going to be a very rewarding year and wish to thank our supportive shareholders who have believed in our vision of becoming the dominant solution for product syndication around the world.”

Additionally, and following approval from its Board of Directors, the Company has announced it has granted incentive stock options to directors, officers, employees and consultants for the right to purchase up to an aggregate of 2,600,000 common shares of the Company (the “Options”). 

The Options are exercisable at $0.20 per share for a term of five years. The terms of the Options granted are in accordance with the Company’s Rolling Share Option Plan approved by shareholders at the Annual General Meeting in December 2020. The Options will vest over a two year period and are subject to Exchange approval.

About Venzee Technologies, Inc.

Venzee (TSX-V VENZ) is a technology platform used by Global Brands to speed products to market and create competitive supply chain advantage. Venzee’s Mesh Connector™ technology displaces costly, labor-intensive last-mile retail processes with a low-cost, intelligent platform solution.

We believe intelligent supply chain functionality is inevitable and will significantly benefit growers, makers, brands, sellers, regulators, and consumers. At Venzee, we’re building the foundation for a future where seamless, accurate, automated data flow simplifies processes, removes friction, and creates value for all those that rely on the myriad of data and information surrounding any product, anywhere.

Venzee’s mission is to unlock shareholder value by creating intelligent technology that removes friction from the global supply chain. Our products disrupt and displace inefficient manual processes in favor of integrated, machine-driven solutions.

To learn more about the Venzee platform, visit venzee.com

Twitter: @usevenzee
LinkedIn: https://www.linkedin.com/company/venzee-inc/ 
Podcast: https://www.venzee.com/resources/podcast

On Behalf of the Board,

Annie Dysart

Marketing Specialist
Venzee Technologies, Inc.
[email protected]
888-359-8110

Investor Relations
Kin Communications, Inc.
[email protected]  
604-684-6730

Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the terms of the Offering, the completion of the Offering and the expected use of the net proceeds received by the Company. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to: general business, economic, competitive, geopolitical and social uncertainties; and regulatory risks. Additional information about these assumptions and risks and uncertainties is contained under “Risk Factors and Uncertainties” in the Company’s management’s discussion and analysis for the year ended December 31, 2018, and the quarter ended August 29, 2019, which are available under the Company’s SEDAR profile at www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future.

Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The forward-looking information contained in this news release is expressly qualified in its entirety by this cautionary statement.

The Company does not undertake to update any forward-looking information, except as required by applicable securities laws.

Neither TSX-V nor its Regulation Services Provider (as that term is defined in policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:http://www.prnewswire.com/news-releases/venzee-technologies-receives-over-1-6m-from-warrants-exercises-in-q1-2021–301260235.html

SOURCE Venzee Technologies Inc.